Treatment of Chronic Hepatitis C: Efficacy, Side Effects and Complications

Visceral Medicine
Lisa SandmannBenjamin Maasoumy

Abstract

Chronic hepatitis C virus (HCV) infection can lead to liver cirrhosis and its complications. Viral eradication is essential to prevent disease progression and reduces liver-related mortality and morbidity. Since the availability of direct-acting antivirals (DAA), HCV treatment has changed significantly. Current treatment strategies for different groups of patients as well as potential risks and caveats will be discussed in this review. Interferon-free (IFN-free) treatment not only shortens treatment duration, but also achieves high rates of viral clearance and is overall well tolerated. Genotype-restricted but also pangenotypic combinations are available. Usually two DAA of different drug classes are combined. For the majority of the patients, treatment duration ranges from 8 to 12 weeks. Liver and kidney function as well as prior treatment experience and potential drug-drug interactions influence substance choices and treatment duration. However, modern IFN-free treatment is not only safer, but also overall far more simplified and effective. Global HCV eradication might be an ambitious but not completely unrealistic goal to pursue. IFN-free antiviral treatment is safe and well tolerated. Patients can be treated almost independ...Continue Reading

References

Jan 27, 2004·Transplantation·Ulf P NeumannPeter Neuhaus
Feb 24, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alejandro BlascoMiquel Navasa
Dec 4, 2012·Best Practice & Research. Clinical Gastroenterology·Benjamin Maasoumy, Heiner Wedemeyer
Mar 19, 2013·The Lancet Infectious Diseases·Michael P Manns, Markus Cornberg
Oct 5, 2013·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·David Back, Laura Else
Nov 12, 2014·JAMA : the Journal of the American Medical Association·Adriaan J van der MeerHarry L A Janssen
Jan 6, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Christoph Höner Zu SiederdissenMarkus Cornberg
May 20, 2015·Gastroenterology·Michael CharltonUNKNOWN SOLAR-1 Investigators
Nov 17, 2015·The New England Journal of Medicine·Michael P CurryUNKNOWN ASTRAL-4 Investigators
Nov 28, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christoph Höner Zu SiederdissenHeiner Wedemeyer
Dec 15, 2015·Journal of Hepatology·Martin-Walter WelkerChristoph Sarrazin
Feb 2, 2016·Journal of Hepatology·Graham R FosterUNKNOWN HCV Research, UK
Mar 1, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Varun SaxenaUNKNOWN HCV-TARGET
Oct 21, 2016·Antiviral Therapy·Edward J GaneJohn G McHutchison
Jul 10, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Cheng WangGeorge Lau
Jun 1, 2017·The New England Journal of Medicine·Marc BourlièreUNKNOWN POLARIS-1 and POLARIS-4 Investigators
Jun 24, 2017·Gastroenterology·Fasiha KanwalHashem B El-Serag
Aug 27, 2017·Journal of Hepatology·Juan Manuel PascasioMaría-Carlota Londoño
Sep 30, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·Christoph Höner Zu SiederdissenKatja Deterding
Oct 12, 2017·The New England Journal of Medicine·Edward GaneFederico J Mensa
Nov 21, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fred PoordadFederico J Mensa
Apr 14, 2018·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, UNKNOWN European Association for the Study of the Liver
Apr 16, 2018·Gastroenterology·Vincenza CalvarusoUNKNOWN Rete Sicilia Selezione Terapia–HCV (RESIST-HCV)
Apr 20, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nancy ReauXavier Forns
Apr 21, 2018·Liver International : Official Journal of the International Association for the Study of the Liver· Manoj KumarShiv K Sarin
Jul 18, 2018·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Steven FlammFederico J Mensa
Sep 28, 2018·Clinical Pharmacokinetics·Elise J SmoldersDavid M Burger

❮ Previous
Next ❯

Citations

Feb 29, 2020·Microbiology and Immunology·Yue LuLeiliang Zhang
Oct 12, 2020·International Journal of Public Health·Lubomír SkladanýPeter Jarčuška
Dec 22, 2020·Frontiers in Microbiology·Zelalem A MekonnenBranka Grubor-Bauk
Feb 12, 2020·Heliyon·Shruti MishraSiddharth Manvati
Apr 29, 2020·Cold Spring Harbor Perspectives in Medicine·Johannes SchwerkMichael Gale
Feb 13, 2021·International Journal of Molecular Sciences·Andrea CitarellaNicola Micale
Feb 9, 2021·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Parmvir ParmarCurtis L Cooper
Mar 4, 2021·Liver International : Official Journal of the International Association for the Study of the Liver·Aleksandra Berkan-KawińskaRobert Flisiak
Dec 16, 2020·Minerva medica·Stefano GittoPietro Andreone
Sep 13, 2020·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Alessio AghemoUNKNOWN MARS Study Group
Jun 18, 2021·Health Science Reports·Christoph SarrazinMarcus-Alexander Wörns
Jul 3, 2021·International Journal of Molecular Sciences·Suyun JeongWonchae Choe
Jun 25, 2021·World Journal of Gastroenterology : WJG·Patricia Holanda AlmeidaYuri L Boteon
Sep 30, 2021·Journal of Viral Hepatitis·Jacey NishiguchiDavid E Smith

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.